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Abstract 
Chronic use of various recreational drugs is leading to drug abuse which is increasingly developed in the 
modern society among the various populations throughout the world. The present study was conducted to 
investigate the impact of a few recreational drugs viz., anabolic androgenic steroids (AAS), alcohol and 
nicotine on male fertility status which was assessed by measuring sperm count in male albino mice. Semen 
samples were collected from normal, AAS-treated, alcohol-treated and nicotine-treated  mice and the sperm 
count (in millions/ml semen) was assessed at regular intervals i.e. on 10th, 20th, 30th, 45th,60th,75th and 90th day 
of treatment during the experimental period of 90 days. The results showed a significant decrease in the 
sperm count in AAS-treated, nicotine-treated (p<0.01) and alcohol-treated mice (p<0.05) compared to that of 
the normal mice. The present study clearly indicates suppression of sperm count on AAS, alcohol and 
nicotine treatment which may be one of the contributing factors in male infertility. 
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1. Introduction 
Infertility, a critical component of reproductive health, is a major public health problem in the modern 
society. It affects 10-15% of couples across the globe [1]. It can lead to distress and depression, as well as 
discrimination and ostracism among married couples [2,3]. Male factor infertility is considered to be the sole 
contributing factor in conception difficulties of up to 40% of infertile couples [4]. Male reproductive 
pathologies can be congenital or acquired, characterized by reduced sperm count due to impaired 
spermatogenesis or abnormal maturation, and sperm dysfunction caused by metabolic deregulation or 
oxidative stress [5-8]. Although in some men a specific disorder may be present, in majority of them no 
apparent reason for infertility has been reported. In the present day scenario, lifestyle factors like recreational 
drug abuse is considered to be an important cause of male factor infertility which includes the use of 
anabolic-androgenic steroids (AAS), alcohol, nicotine, marijuana, opioid  narcotics, cocaine etc. [9].  
The abuse of AAS is under constant debate worldwide. A large number of young adolescents abuse AAS in 
order to improve their physical fitness and appearance. While formerly restricted to competing athletes now 
AAS are also abused by non-competitive adolescent athletes as well as non-athletic sub-groups to gain 
euphoria [10-18]. One of the most pronounced effects of AAS abuse is its negative impact on the 
hypothalamic-pituitary-gonadal axis [19]. AAS via negative feedback to hypothalamus induce 
hypogonadotrophic-hypogonadism associated with decreased serum testosterone concentrations, testicular 
atrophy, impaired steroidogenesis and spermatogenesis [20-22]. AAS abuse leads to marked depression of 
serum testosterone, sex hormone-binding globulin (SHBG) as well as gonadotrophins i.e., luteinizing 
hormone (LH) and follicle-stimulating hormone (FSH) [23,24]. 
The stringent legislative regulations imposed by health regulatory authorities over the production and use of 
opiates, cannabinoids, and their synthetic analogues have resulted into an increased consumption of 
substances like tobacco and alcohol [25]. Tobacco (Nicotiana tabacum) and alcohol (ethanol) are considered 
to be the largest consumed addictive substances by the people irrespective of age, sex, social and economic 
status, in all sub- continents of the globe [26]. A number of studies have shown that long term chronic intake 
of nicotine and alcohol has serious detrimental effects on male sexual functioning. Chronic users suffer from 
impotence, loss of libido, premature or delayed ejaculation, decline in testosterone levels, decreased sperm 
count and sperm maturation, thereby, affecting sexual potential in the form of infertility [27-29]. 
However, many workers at different times have reported their results of investigation on effects of various 
drugs at clinical and subclinical doses and their role in different metabolic pathways but the reports of 
investigation on complicated mesh of relationship among the types of drugs, dosage of drugs and their 
differential effect on the process of spermatogenesis are still fragmentary. Therefore, the aim of the present 
study is to investigate the impact of a few recreational drugs viz. anabolic androgenic steroids (AAS), alcohol 
and nicotine on male fertility status in albino mice. 
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2. Materials and Methods 
2.1 Animals 
One hundred and forty (140) adult male albino mice, weighing between 20-25 g (three to four months old), 
were randomly selected from the animal house of the Zoology Department of Gauhati University, Guwahati, 
Assam (India) after approval of the Ethical Committee of Animal Welfare of Gauhati University. Before 
starting the experimental procedure, all the animals were acclimatized in the animal room for four weeks and 
fed on standard animal diet. Adequate measures were taken to minimize pain or discomfort to the mice and 
the experiments were conducted in accordance with international standards on animal welfare and were also 
compliant with local and national regulations. 
2.2 Animal Grouping and Treatment 
The 140 animals were randomly divided into four different groups of 35 each as follows: 
Group-I (Normal Group), receiving normal standard diet but did not receive any treatment; 
Group-II (AAS-treated Group), receiving intramuscular injection of 0.1ml of 2.5 mg of nandrolone 
decanoate weekly during the experimental period of 13 weeks. In the present study, a dose of 2.5 mg 
Nandrolone decanoate is chosen only to ascertain the effect in this particular dose. Doses were selected as 
100mg/kg body weight [30,31].  
Group-III (Alcohol-treated Group), receiving 15 ml of 10% ethanol per day orally during the experimental 
period of 90 days. 
Group – IV (Nicotine-treated Group), receiving oral administration of 120 µg nicotine per day from 1st day 
to 30th day, 240 µg nicotine per day from 31st day to 60th day and 480 µg nicotine per day from 61st day to 
90th day during the experimental period of 90 days. Nicotine is administered orally in a series of three doses, 
viz. 4,8 and 16 mg/kg body weight respectively [32]. 
2.3 Semen Collection, Preparation of spermatozoa and Estimation of Sperm Count 
The male albino mice of normal and different experimental groups were sacrificed on 10th, 20th, 30th, 
45th,60th,75th and 90th day of treatment for collection of semen samples. The animals were anaesthetized with 
diethyl ether by using an anaesthetic mask and a “T” incision is made from pubic symphysis to the upper 
abdomen for exposing the abdominal region. The testis, epididymis, seminal vesicle, prostate gland and vas 
deferens were dissected out immediately and separated from the adherent tissue. Caudae epididymidis and 
vasa deferentia were excised and rinsed with medium containing 150 mM NaCl, 5 mM KCl, 2mM CaCl2, 1 
mM MgCl2, 30 mM HEPES, 10 mM glucose, 10 mM lactic acid, and 1 mM pyruvic acid (pH 7.4) which 
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were then transferred to 1 ml of medium supplemented with 5 mg of bovine serum albumin per ml and 15 
mM NaHCO3. Semen was allowed to exude (15 min at 37°C, 5% CO2) from three to five small incisions. 
Cells were diluted to 4 ml and collected twice by sedimentation (400 g; 5 min) [33]. The sperm count was 
measured using Neubaeur chamber [34]. 
2.4 Statistical Analysis 
The results obtained were statistically analyzed for t-test, percentage deviation, coefficient of variation (CV) 
and others following Croxton [35].  
3. Results 
The obtained results were summarized in Table 1. The data were presented as mean ± SEM. The analysis 
revealed decrease in the sperm count in AAS-treated, alcohol-treated as well as nicotine-treated mice 
compared to that of the normal mice. 
Table 1. Presenting the mean values of sperm count (in millions/ml) of different groups at different days 
interval. 
 
GROUPS 
DAYS OF TREATMENT 
10th 20th 30th 45th 60th 75th 90th 
GROUP-I 
(NORMAL 
GROUP) 
 
44.46±0.99 
 
 
44.58± 1.55 
 
 
44.68±1.15 
 
 
45.1 ± 1.93 
 
 
44.82±2.42 
 
 
45.1±1.91 
 
 
44.52 ±1.60 
 
GROUP-II 
(AAS-
TREATED 
GROUP) 
 
42.35± 1.72* 
 
\ 
42.5± 1.37* 
 
 
40.85± 
1.47** 
 
36.54± 
0.83*** 
 
 
30.45±  
1.37*** 
 
 
31.37± 
1.18*** 
 
 
30.23± 
1.23*** 
 
GROUP-III 
(ALCOHOL 
-TREATED 
GROUP) 
 
44.23± 1.95* 
 
 
42.25± 3.02* 
 
 
42.72± 
1.88* 
 
 
40.05± 
1.68** 
 
 
41.38± 
2.34* 
 
 
37.85± 
1.93** 
 
 
37.25± 
2.78** 
 
GROUP-IV 
(NICOTINE 
-TREATED 
GROUP) 
 
 
43.81± 2.79* 
 
 
42.11± 2.15* 
 
 
42.25± 
1.92* 
 
 
42.05± 
2.39* 
 
 
38.85± 
1.39** 
 
 
38.37± 
1.71** 
 
 
34.72± 
2.21*** 
 
Mean values are expressed as mean ± SEM.  
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* Not significant at p > 0.05;  
** significant at p < 0.05; 
*** highly significant at p < 0.01 
In the group of animals administered with anabolic  androgenic steroid (AAS), the mean values of sperm 
count were found to be in decreasing trend which were recorded as 42.35 ± 1.72 millions/ml on 10th day to 30 
± 1.23 millions/ml on 90th day of treatment. 
In the alcohol treated group of animals, the mean values of sperm count were found to be  in decreasing trend 
as 44.23 ± 1.95  on 10th day to 37.25 ± 2.78 millions/ml on 90th day of treatment. 
In the group of animals treated with nicotine, the mean values of sperm count were found to be in decreasing 
trend in the range of 43.81 ± 2.79 to 34.72 ± 2.21 millions /ml during the experimental period of 90 days. 
 
Fig 1. Presenting the percentage deviation of sperm count (in millions/ml) of different experimental groups from mean 
value of normal group. 
4. Discussion 
In the present investigation, with the experimental dosage (2.5 mg/week) of nandrolone decanoate, a highly 
significant decrease (p<0.01) in the sperm count (in millions/ml semen) was observed during the 
experimental period of 90 days. However, decrease in sperm count was found to be insignificant upto 20th 
day, significant on 30th day and highly significant from 45th day onwards which was sustained upto the 
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terminal part of the experimental period (Table 1). On 90th day of treatment, the mean value was found to be 
lowest with 32.09% declination from the normal base line (Fig. 1). 
In case of alcohol-treated group, with the experimental dosage of alcohol (15 ml of 10% ethanol), a 
significant decrease (p<0.05) in the sperm count (in millions/ml semen) was recorded during the experimental 
period of 90 days. The decline in the sperm count was found to be insignificant upto 30th day whereas it was 
observed to be significant on 45th, 75th and 90th day of treatment (Table 1) with 16.33% declination from the 
normal base line on 90th day (Fig. 1). 
In the nicotine-treated group of mice, the decline in sperm count was found to be insignificant upto 45th day 
of treatment which gradually declined towards the end of the experimental period with highest amount of 
declination (22.01%) from the normal base line on 90th day (Fig. 1). This reduction in sperm count was 
observed to be positively correlated with the duration of treatment (Table 1). 
The present investigation clearly depicts early declination of sperm count i.e., after 20th day in case AAS 
treatment followed by alcohol i.e., after 30th day and finally nicotine i.e., after 45th day of treatment (Table 1). 
Though delayed impact was observed in case of nicotine treatment, the effect was found to be more 
pronounced in case of nicotine i.e., 22.01% than that of alcohol i.e., 16.33% towards the end of the 
experimental set-up (Fig. 1). However, maximum declination i.e., 32.09% below normal base line was 
recorded in case of AAS treatment (Fig. 1). 
Thus, the findings of the present investigation are in conformity with the previous reports and clearly 
indicates suppression of sperm count on AAS, alcohol and nicotine treatment which may impair the fertility 
status.  However, further investigation is needed to correlate the effect of recreational drugs with male 
infertility. 
5. Conclusion 
It can be concluded from the present investigation conducted for a period of 90 days that sperm count is 
maximally suppressed on chronic administration of AAS, followed by nicotine and alcohol respectively. 
However, further study for longer duration is required in order to support the authenticity of the results. 
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